Impact of erythropoietin on arterial hypertension

Cardiovascular and renal diseases constitute two pathophysiological contexts of progressive fatal recognitions worldwide as priorities in terms health its entirety. Erythropoietin is a glycoprotein hormone which produces red blood cells, carry oxygen the blood. The objective was to know most prevalent modifiable risk factors found arterial hypertension, since this disease third cause death world, bibliographic search inductive-deductive method were used. result that treatment with recombinant human erythropoietin-stimulating agents considered effective improving management anemia associated chronic kidney disease, it has cardioprotective, renoprotective neuroprotective functions.